Codexis (CDXS) Common Equity (2010 - 2026)
Codexis (CDXS) posted quarterly Common Equity of $43.2 million for Q1 2026, down 12.89% year-over-year from $49.6 million in Q1 2025, and down 14.44% quarter-over-quarter from $50.5 million in Q4 2025.
Codexis (CDXS) Common Equity (2010 - 2026) Analysis & Trends
Codexis' Common Equity history runs 17 years deep, the most recent figure standing at $43.2 million for Q1 2026.
- In Q1 2026, Common Equity fell 12.89% year-over-year to $43.2 million; the TTM figure through Mar 2026 stood at $43.2 million (down 12.89% YoY), while the FY2025 annual figure was $50.5 million, down 24.5% from the prior year.
- Common Equity for Q1 2026 stood at $43.2 million, down from $50.5 million in the prior quarter.
- The five-year high for Common Equity was $159.5 million in Q2 2022, with the low at $38.5 million in Q3 2025.
- The 5-year median for Common Equity is $79.3 million (2024), against an average of $92.0 million.
- The sharpest annual moves came in 2022 and 2024: Common Equity decreased 2.04% in 2022, then plunged 50.5% in 2024.
- Codexis' Common Equity stood at $144.8 million in 2022, then slumped by 40.18% to $86.6 million in 2023, then slipped by 22.73% to $66.9 million in 2024, then fell by 24.5% to $50.5 million in 2025, then fell by 14.44% to $43.2 million in 2026.
- Business Quant data shows CDXS's Common Equity at $43.2 million in Q1 2026, $50.5 million in Q4 2025, and $38.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | 9.79 Bn |
| 10 | Codexis | 144.77 Mn | 89.86 Mn | 11.40 Mn | 32.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.96 Mn |
| Mar 31, 2026 | 43.23 Mn |
| Dec 31, 2025 | 50.53 Mn |
| Sep 30, 2025 | 38.54 Mn |
| Jun 30, 2025 | 55.63 Mn |
| Mar 31, 2025 | 49.63 Mn |
| Dec 31, 2024 | 66.93 Mn |
| Sep 30, 2024 | 73.40 Mn |
| Jun 30, 2024 | 61.45 Mn |
| Mar 31, 2024 | 79.27 Mn |
| Dec 31, 2023 | 86.62 Mn |
| Sep 30, 2023 | 91.51 Mn |
| Jun 30, 2023 | 124.13 Mn |
| Mar 31, 2023 | 126.02 Mn |
| Dec 31, 2022 | 144.80 Mn |
| Sep 30, 2022 | 154.13 Mn |
| Jun 30, 2022 | 159.46 Mn |
| Mar 31, 2022 | 158.64 Mn |
| Dec 31, 2021 | 164.39 Mn |
| Sep 30, 2021 | 169.06 Mn |